Status:
UNKNOWN
Myopia Progression With a Novel Extended Depth of Focus Contact Lens
Lead Sponsor:
Aller, Thomas A., OD
Collaborating Sponsors:
Visioneering Technologies, Inc
Conditions:
Myopia
Myopia, Progressive
Eligibility:
All Genders
5-25 years
Brief Summary
Myopia has been increasing in prevalence and severity throughout the world over the last 30 years. Increasing levels of myopia are associated with increased frequencies and severity of various ocular ...
Detailed Description
Myopia has been increasing in prevalence and severity throughout the world over the last 30 years. Increasing levels of myopia are associated with increased frequencies and severity of various ocular ...
Eligibility Criteria
Inclusion
- Myopic refractive error
- Astigmatism less than -2.50 D
- Evidence from clinical record of myopia progression equal to or greater than -0.50 D in at least one eye since the prior examination
- Ability to see 20/30 or better in the worse eye and 20/25 or better binocularly after one week adaptation
- Ability to properly insert, remove and care for study lens
Exclusion
- Moderate to severe allergic conjunctivitis
- Moderate to severe dry eyes
- Keratoconus or other related corneal irregularity
- Strabismus
- Amblyopia
- Nystagmus
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03358862
Start Date
January 1 2017
End Date
July 1 2022
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Thomas Aller Optometrist, Inc.
San Bruno, California, United States, 94066